USA - NASDAQ:RCM - US77634L1052 - Common Stock
The current stock price of RCM is 14.31 USD. In the past month the price increased by 0.49%. In the past year, price increased by 32.13%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.41 | 99.12B | ||
| CI | THE CIGNA GROUP | 8.6 | 65.24B | ||
| LH | LABCORP HOLDINGS INC | 16.05 | 21.10B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 200.69 | 19.55B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.03 | 19.67B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.35 | 15.75B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.60B | ||
| HIMS | HIMS & HERS HEALTH INC | 56.83 | 10.27B | ||
| DVA | DAVITA INC | 12.27 | 8.51B | ||
| CHE | CHEMED CORP | 19.6 | 6.28B | ||
| RDNT | RADNET INC | 211.08 | 5.85B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 60.09 | 5.85B |
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. The company is headquartered in Murray, Utah and currently employs 29,400 full-time employees. The company went IPO on 2010-05-25. The Company’s scalable operating models seamlessly complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The firm delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. The company serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.
R1 RCM Inc
434 W. Ascension Way, 6Th Floor
Murray UTAH 60611 US
CEO: Joseph Flanagan
Employees: 29650
Phone: 13123247820
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. The company is headquartered in Murray, Utah and currently employs 29,400 full-time employees. The company went IPO on 2010-05-25. The Company’s scalable operating models seamlessly complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The firm delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. The company serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.
The current stock price of RCM is 14.31 USD. The price increased by 0.07% in the last trading session.
RCM does not pay a dividend.
RCM has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
19 analysts have analysed RCM and the average price target is 14.89 USD. This implies a price increase of 4.07% is expected in the next year compared to the current price of 14.31.
R1 RCM Inc (RCM) operates in the Health Care sector and the Health Care Providers & Services industry.
R1 RCM Inc (RCM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
ChartMill assigns a technical rating of 7 / 10 to RCM. When comparing the yearly performance of all stocks, RCM turns out to be only a medium performer in the overall market: it outperformed 69.86% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to RCM. RCM may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months RCM reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS decreased by -66.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.06% | ||
| ROE | -2.18% | ||
| Debt/Equity | 0.76 |
19 analysts have analysed RCM and the average price target is 14.89 USD. This implies a price increase of 4.07% is expected in the next year compared to the current price of 14.31.